Stress triggers energy-dependent, anticipatory responses that promote survival, a phenomenon termed allostasis. However, the chronic activation of allostatic responses results in allostatic load (AL) and in the maladaptive state known as allostatic overload. Epidemiological studies show that allostatic load predicts physical and cognitive decline, as well as earlier mortality; yet the manifestations of allostatic load and overload at the cellular level remain unclear. To define the energetic cost and potential detrimental effects of prolonged cellular allostatic load, we developed a longitudinal model of chronic glucocorticoid stress in primary human fibroblasts. Results replicated in three healthy donors demonstrated that chronic stress robustly increased cellular basal energy consumption by 62%. This hypermetabolic state relied on a bioenergetic shift away from glycolysis towards mitochondrial oxidative phosphorylation (OxPhos), supported by an upregulation of mitochondrial biogenesis and increased mitochondrial DNA (mtDNA) density. As in humans where chronic stress accelerates biological aging, chronic allostatic load altered extracellular cytokine and cell-free DNA, caused mtDNA instability, increased the rate of epigenetic aging based on DNA methylation clocks, accelerated telomere shortening, and reduced lifespan (i.e., Hayflick limit). Pharmacological blockade of mitochondrial nutrients uptake normalized OxPhos activity but exacerbated hypermetabolism, which further accelerated telomere shortening and reduced cellular lifespan. Together, these results highlight the increased energetic cost of cellular allostatic load and suggests a mechanism for the transduction of chronic stress into accelerated cellular aging to be examined in humans.